Fresenius Medical Care (FMS) Stock Price, News & Analysis

-0.43 (-1.92%)
(As of 05/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
481,615 shs
Average Volume
434,615 shs
Market Capitalization
$12.89 billion
P/E Ratio
Dividend Yield
Price Target

Fresenius Medical Care MarketRank™ Stock Analysis

Analyst Rating
2.14 Rating Score
9.3% Upside
$24.00 Price Target
Short Interest
0.24% of Shares Sold Short
Dividend Strength
Based on Four Factors
News Sentiment
1.17mentions of Fresenius Medical Care in the last 14 days
Based on 10 Articles This Week
Insider Trading
Proj. Earnings Growth
From $1.49 to $1.89 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.45 out of 5 stars

Medical Sector

492nd out of 923 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

7th out of 8 stocks

FMS stock logo

About Fresenius Medical Care Stock (NYSE:FMS)

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FMS Stock Price History

FMS Stock News Headlines

Fresenius Medical Care (NYSE:FMS) Shares Gap Up to $20.88
Fresenius Medical Care 1Q Net Pft EUR71M
FMS Fresenius Medical Care AG
FMS Oct 2024 20.000 call
FMS Jul 2024 17.500 call
Why Dialysis Stocks Are Up This Morning
See More Headlines
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Ex-Dividend for 6/3 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Miscellaneous health & allied services, not elsewhere classified
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
7 Analysts


Net Income
$540.07 million
Pretax Margin


Sales & Book Value

Annual Sales
$21.05 billion
Cash Flow
$4.54 per share
Book Value
$28.00 per share


Free Float
Market Cap
$12.89 billion

Social Links

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Ms. Helen Giza (Age 56)
    CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG
    Comp: $5.25M
  • Mr. Martin Fischer (Age 47)
    CFO & Member of the Management Board of Fresenius Medical Care Management AG
    Comp: $944.42k
  • Dr. Franklin W. Maddux F.A.C.P. (Age 67)
    Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG
    Comp: $2.95M
  • Dr. Katarzyna Mazur-Hofsab Ph.D. (Age 61)
    Management Board Member for Care Enablement of Fresenius Medical Care Management AG
    Comp: $3.07M
  • Mr. Craig Cordola FACHE (Age 54)
    M.B.A., M.H.A., CEO of Care Delivery & Member of Management Board
  • Dr. Dominik Heger
    Executive VP and Head of Investor Relations, Strategic Development & Communications
  • Mr. Joachim Weith
    Senior Vice President of Corporate Communications & Governmental Affairs
  • Dr. Gail-Suzanne Brown
    Senior Vice President of Research & Development
  • Mr. Glenn Slater
    Senior Vice President of Manufacturing and Supply Chain Operations
  • Dr. Wolfgang Kummerle
    Senior Vice President - Quality Management International

FMS Stock Analysis - Frequently Asked Questions

Should I buy or sell Fresenius Medical Care stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings
or view top-rated stocks.

What is Fresenius Medical Care's stock price target for 2024?

7 Wall Street analysts have issued 1 year target prices for Fresenius Medical Care's stock. Their FMS share price targets range from $24.00 to $24.00. On average, they anticipate the company's share price to reach $24.00 in the next twelve months. This suggests a possible upside of 9.3% from the stock's current price.
View analysts price targets for FMS
or view top-rated stocks among Wall Street analysts.

How have FMS shares performed in 2024?

Fresenius Medical Care's stock was trading at $20.83 at the beginning of 2024. Since then, FMS stock has increased by 5.4% and is now trading at $21.9650.
View the best growth stocks for 2024 here

Are investors shorting Fresenius Medical Care?

Fresenius Medical Care saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,400,000 shares, an increase of 28.4% from the April 15th total of 1,090,000 shares. Based on an average daily volume of 460,700 shares, the days-to-cover ratio is currently 3.0 days.
View Fresenius Medical Care's Short Interest

When is Fresenius Medical Care's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024.
View our FMS earnings forecast

How were Fresenius Medical Care's earnings last quarter?

Fresenius Medical Care AG (NYSE:FMS) posted its quarterly earnings results on Tuesday, February, 20th. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.11. The company earned $5.37 billion during the quarter, compared to analysts' expectations of $5.32 billion. Fresenius Medical Care had a net margin of 2.48% and a trailing twelve-month return on equity of 5.29%.

How often does Fresenius Medical Care pay dividends? What is the dividend yield for Fresenius Medical Care?

Fresenius Medical Care announced an annual dividend on Monday, April 15th. Stockholders of record on Monday, May 20th will be given a dividend of $0.437 per share on Monday, June 3rd. This represents a dividend yield of 2.35%. The ex-dividend date is Friday, May 17th.
Read our dividend analysis for FMS

Is Fresenius Medical Care a good dividend stock?

Fresenius Medical Care (NYSE:FMS) pays an annual dividend of $0.42 per share and currently has a dividend yield of 1.85%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 47.19%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 22.22% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

What ETFs hold Fresenius Medical Care's stock?

ETFs with the largest weight of Fresenius Medical Care (NYSE:FMS) stock in their portfolio include Cultivar ETF (CVAR).Pacer Developed Markets International Cash Cows 100 ETF (ICOW).

What other stocks do shareholders of Fresenius Medical Care own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

Who are Fresenius Medical Care's major shareholders?

Fresenius Medical Care's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Pzena Investment Management LLC (2.77%), Partnership Wealth Management LLC (0.02%), Triasima Portfolio Management inc. (0.01%), QRG Capital Management Inc. (0.01%), Veracity Capital LLC (0.01%) and Uncommon Cents Investing LLC (0.01%).

How do I buy shares of Fresenius Medical Care?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Fresenius Medical Care have any subsidiaries?
The following companies are subsidiares of Fresenius Medical Care: NxStage Medical.
Read More
This page (NYSE:FMS) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners